Dr. Tori Hudson, Naturopathic Physician, has been in practice since 1984, over 42 years. She is currently medical Director at A Woman’s Time, clinical adjunct professor at all the naturopathic medical schools in the US and Canada, co-owner of Vitanica and the founder and co-director of NERC (Naturopathic Education and Research Consortium), a non-profit organization for accredited naturopathic residencies.
Dr Hudson has received numerous awards within the naturopathic profession, the botanical profession and from the natural products industry. She is a nationally recognized author, speaker, educator, researcher, and clinician. She is nationally well known for her expertise in women’s health, including menopause, genitourinary syndrome of menopause and hormone interventions for quality of life, select disease risk reduction and treatment.
Lecture 1:
Genitourinary Syndrome of Menopause:
Recognition, Evaluation, and Evidence-Based Treatment
Day & Time, TBD
Vaginal discomfort, painful intercourse, and urinary symptoms can affect intimacy, daily function, and quality of life, yet patients may hesitate to bring them up. Naturopathic doctors are well positioned to initiate these conversations and provide individualized care.
This clinically focused presentation explores recognition, evaluation, and evidence-based management of genitourinary syndrome of menopause (GSM). Attendees will learn to connect symptoms with examination findings, distinguish GSM from other causes of vulvovaginal and urinary complaints, and identify when further evaluation is needed. Practical treatment guidance will address local hormonal and nonhormonal therapies, including formulation selection, dosing, delivery methods, and safety considerations. Emphasis will be placed on shared decision-making, patient education, and follow-up to support comfort, sexual health, and urinary function.
After the presentation, participants will be able to confidently:
Recognize the vaginal, sexual, and urinary manifestations of GSM and use sensitive, targeted questions to identify concerns patients may not volunteer.
Perform a focused history and examination to identify characteristic findings, assess alternative diagnoses, and recognize indications for referral.
Counsel patients about the persistent nature of GSM, its potential effects on quality of life, and the role of ongoing management.
Develop individualized, evidence-based treatment plans using local hormonal and nonhormonal therapies, selecting appropriate formulations, doses, and delivery methods while addressing safety, preferences, and follow-up.
Lecture 2:
Testosterone Therapy in Perimenopause and Menopause:
Evidence, Safety, and Clinical Applications
Day & Time, TBD
This presentation will review the clinical evidence regarding testosterone therapy in peri and postmenopausal women, with a primary focus on its role in the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women. We will evaluate the current literature on efficacy, safety, and prescribing considerations, including off-label use in the U.S. Clinicians will leave with practical, evidence-based strategies for evaluation, prescribing and monitoring.
After the presentation, participants will be able to confidently:
Summarize the physiology of testosterone in biologic females and its role in sexual function.
Describe the evidence base for testosterone therapy in the treatment of HSDD in postmenopausal women.
Review current safety data, including potential risks and adverse effects, from randomized controlled trials and meta-analyses.
Identify practical approaches for prescribing and monitoring testosterone in clinical practice, including dosing, formulations, and lab testing.
Discuss brief evidence-based findings for testosterone’s role in mood, cognition, and musculoskeletal health.

